Balchem Corporation declares a $0.96 dividend per share, marking a 10.3% increase and 17th consecutive rise.
Quiver AI Summary
Balchem Corporation announced on December 9, 2025, that its Board of Directors declared a dividend of $0.96 per share on its common stock, which will be payable on January 20, 2026, to stockholders of record as of December 23, 2025. This dividend marks a 10.3% increase from the previous year and is the seventeenth consecutive increase in annual dividends, showcasing the company's strong financial performance and the Board's confidence in its long-term strategies, according to Chairman, President, and CEO Ted Harris. Balchem specializes in developing, manufacturing, and marketing specialty ingredients across various sectors, including human and animal nutrition, healthcare, and agriculture. The release also includes forward-looking statements, highlighting potential risks and uncertainties regarding the company's future expectations.
Potential Positives
- Balchem Corporation announced a dividend of $0.96 per share, reflecting a 10.3% increase over last year’s annual dividend, signaling strong financial performance.
- This marks the seventeenth consecutive increase in the annual dividend, demonstrating the company's consistent commitment to returning value to shareholders.
- The announcement reinforces the Board's confidence in the company's long-term strategies, which can positively impact investor sentiment.
- Balchem's diverse business segments, including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products, indicate a robust foundation for continued growth and profitability.
Potential Negatives
- While announcing a dividend increase can be seen as positive, it may also indicate a lack of alternate growth opportunities if the company is opting to return cash to shareholders instead of reinvesting in business development.
- The inclusion of forward-looking statements accompanied by risks and uncertainties could raise concerns among investors about the company's ability to meet expectations and navigate future challenges successfully.
- Failure to provide specific details regarding the factors that may lead to discrepancies between expected and actual results may contribute to investor skepticism about the company’s future performance.
FAQ
What is the recent dividend declared by Balchem Corporation?
Balchem Corporation declared a dividend of $0.96 per share, payable on January 20, 2026.
When will Balchem's dividend be payable?
The dividend will be payable on January 20, 2026, to stockholders of record as of December 23, 2025.
How much has Balchem's dividend increased this year?
This year's dividend represents a 10.3% increase over last year's annual dividend.
What does Balchem Corporation specialize in?
Balchem develops specialty ingredients for human and animal nutrition and health, alongside specialty products for various industries.
How many consecutive years has Balchem increased its dividend?
This dividend marks the seventeenth consecutive increase in Balchem's annual dividend.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BCPC Insider Trading Activity
$BCPC insiders have traded $BCPC stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $BCPC stock by insiders over the last 6 months:
- DAVID B FISCHER has made 0 purchases and 2 sales selling 8,000 shares for an estimated $1,231,748.
- GUNSTEREN JOB LEONARD VAN (SVP and GM, Specialty Products) has made 0 purchases and 2 sales selling 6,000 shares for an estimated $919,722.
- MARTIN LUTHER REID (SVP Chief Supply Chain Officer) sold 1,200 shares for an estimated $185,328
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCPC Revenue
$BCPC had revenues of $267.6M in Q3 2025. This is an increase of 11.51% from the same period in the prior year.
You can track BCPC financials on Quiver Quantitative's BCPC stock page.
$BCPC Hedge Fund Activity
We have seen 192 institutional investors add shares of $BCPC stock to their portfolio, and 205 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ASSENAGON ASSET MANAGEMENT S.A. added 191,621 shares (+221.3%) to their portfolio in Q3 2025, for an estimated $28,754,647
- FMR LLC removed 170,753 shares (-24.3%) from their portfolio in Q3 2025, for an estimated $25,623,195
- APG ASSET MANAGEMENT N.V. removed 145,734 shares (-61.1%) from their portfolio in Q3 2025, for an estimated $21,868,844
- CONESTOGA CAPITAL ADVISORS, LLC added 125,411 shares (+10.9%) to their portfolio in Q3 2025, for an estimated $18,819,174
- WASATCH ADVISORS LP added 121,147 shares (+12.6%) to their portfolio in Q3 2025, for an estimated $18,179,318
- FIRST TRUST ADVISORS LP added 115,417 shares (+84.7%) to their portfolio in Q3 2025, for an estimated $17,319,475
- TWO SIGMA ADVISERS, LP added 114,200 shares (+94.4%) to their portfolio in Q3 2025, for an estimated $17,136,852
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCPC Analyst Ratings
Wall Street analysts have issued reports on $BCPC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/22/2025
To track analyst ratings and price targets for $BCPC, check out Quiver Quantitative's $BCPC forecast page.
$BCPC Price Targets
Multiple analysts have issued price targets for $BCPC recently. We have seen 2 analysts offer price targets for $BCPC in the last 6 months, with a median target of $176.0.
Here are some recent targets:
- Artem Chubarov from Rothschild & Co set a target price of $162.0 on 12/05/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $190.0 on 10/22/2025
Full Release
MONTVALE, N.J., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that on December 9, 2025, its Board of Directors declared a dividend on its shares of common stock equal to $0.96 per share on the Company’s issued and outstanding Common Stock, to be payable on January 20, 2026 to stockholders of record at the close of business on December 23, 2025. This dividend represents an 10.3% increase over last year’s annual dividend.
Ted Harris, Balchem’s Chairman, President and CEO, said, “Balchem has a longstanding commitment to an annual dividend and we are pleased to announce the continuation of that commitment. This dividend represents the seventeenth consecutive increase in our annual dividend, reflecting both the consistently outstanding financial performance the company has delivered and the Board’s continued confidence in our long-term strategies.”
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Forward-Looking Statements
This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s Annual Report on Form 10-K for the year ended December 31, 2024 and other factors that may be identified in our other SEC filings. Forward-looking statements are qualified in their entirety by the above cautionary 2 statement. Balchem assumes no obligation to update or revise any forward-looking statements as of any future date.
Contact
:
Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)
